Clinically, mutations in the KIT proto-oncogene have been frequently reported in various cancers, including gastrointestinal stromal tumors [11,12], mast cell tumors [13,14], mastocytosis [15,16], and acute myeloid leukemia (AML) [17]. Here, KIT is linked to acute myeloid leukemia.